Peter Attia· MD
Because with HIV, we think of it by class of drug. You basically have a toolkit of drug classes. And it seems to me that you've done a very eloquent job explaining this. There are basically some fundamental pillars in growth and some fundamental pillars in protection. And when the day comes that we have a toolkit that knows, okay, I've got these three things that can hit this pillar, three things that can hit that pillar, four things that hit this pillar, six things that hit this pillar, nothing that hits this pillar and two things that hits it. I mean, that's, You're in the golden zone when you can start stacking because that's what heart highly active antiretroviral therapy did. It basically put whatever three or four pillars together.